Stoke Therapeutics Inc. (STOK)
undefined
undefined%
At close: undefined
12.06
0.08%
After-hours Dec 13, 2024, 04:00 PM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17
Revenue 8.78M 12.40M - - - - -
Cost of Revenue - 3.54M 2.23M 1.93M 450.00K 214.00K 113.00K
Gross Profit 8.78M 8.87M -2.23M -1.93M -450.00K -214.00K -113.00K
Operating Income -114.77M -104.36M -86.06M -53.04M -35.68M -12.78M -5.55M
Interest Income - 3.12M 120.00K 744.00K 3.35M 270.00K -
Pretax Income -104.70M -101.07M -85.81M -52.24M -32.33M -12.52M -5.56M
Net Income -104.70M -93.11M -84.71M -50.61M -28.52M -12.52M -5.56M
Selling & General & Admin 41.32M 38.92M 31.90M 20.85M 11.91M 4.41M 1.96M
Research & Development 82.23M 77.84M 54.17M 32.20M 23.76M 8.37M 3.60M
Other Expenses - 167.00K 140.00K 57.00K 2.00K -10.00K -4.00K
Operating Expenses 123.55M 116.76M 86.06M 53.04M 35.68M 12.78M 5.55M
Interest Expense - 3.12M 120.00K - - - -
Selling & Marketing Expenses - - - - - - -
Cost & Expenses 123.55M 116.76M 86.06M 53.04M 35.68M 12.78M 5.55M
Income Tax - -7.96M -1.09M -1.63M -3.80M 260.00K -
Shares Outstanding (Basic) 43.99M 38.90M 36.74M 33.49M 17.97M 23.51M 12.79M
Shares Outstanding (Diluted) 43.99M 38.90M 36.74M 33.49M 17.97M 23.51M 12.79M
EPS (Basic) -2.38 -2.39 -2.31 -1.51 -1.59 -0.53 -0.43
EPS (Diluted) -2.38 -2.39 -2.31 -1.51 -1.59 -0.53 -0.43
EBITDA -112.30M -102.81M -83.58M -50.32M -35.23M -12.57M -5.44M
Depreciation & Amortization 2.47M 3.54M 2.23M 1.93M 450.00K 214.00K 113.00K